VIICTR
Profiles
ORIT
Pediatrics RRO
Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
VERSTOVSEK, SRDAN
One or more keywords matched the following items that are connected to
VERSTOVSEK, SRDAN
Item Type
Name
Concept
Pyrrolidines
Academic Article
Dual PI3K/AKT/mTOR inhibitor BEZ235 synergistically enhances the activity of JAK2 inhibitor against cultured and primary human myeloproliferative neoplasm cells.
Academic Article
JAK2 inhibitors for myelofibrosis: why are they effective in patients with and without JAK2V617F mutation?
Academic Article
TG101348, a JAK2-selective antagonist, inhibits primary hematopoietic cells derived from myeloproliferative disorder patients with JAK2V617F, MPLW515K or JAK2 exon 12 mutations as well as mutation negative patients.
Academic Article
Therapeutic potential of JAK2 inhibitors.
Academic Article
Fedratinib in patients with myelofibrosis previously treated with ruxolitinib: An updated analysis of the JAKARTA2 study using stringent criteria for ruxolitinib failure.
Academic Article
Safety and efficacy of fedratinib, a selective oral inhibitor of Janus kinase-2 (JAK2), in patients with myelofibrosis and low pretreatment platelet counts.
Academic Article
How I manage anemia related to myelofibrosis and its treatment regimens.
Search Criteria
Pyrrolidines